Effect of Nutritional Status on Survival Outcome of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP

REFERENCES

• Tisdale , M J . 2002 . Cachexia in cancer patients . Nat Rev Cancer , 2 : 862 – 871 .
   PubMed Web of Science ®Google Scholar
• Gordon , J N , Green , S R and Goggin , P M . 2005 . Cancer cachexia . QJM , 98 : 779 – 788 .
   PubMed Web of Science ®Google Scholar
• McMillan , D C . 2009 . Systemic inflammation, nutritional status and survival in patients with cancer . Curr Opin Clin Nutr Metab Care , 12 : 223 – 226 .
   PubMed Web of Science ®Google Scholar
• Alexandre , J , Gross-Goupil , M , Falissard , B , Nguyen , M L Gornet , J M . 2003 . Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy . Ann Oncol , 14 : 36 – 41 .
   PubMed Web of Science ®Google Scholar
• Arrieta , O , Michel Ortega , R M , Villanueva-Rodriguez , G , Serna-Thome , MG. Flores-Estrada , D . 2010 . Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study . BMC Cancer , 10 : 50
   PubMed Web of Science ®Google Scholar
• Barret , M , Malka , D , Aparicio , T , Dalban , C Locher , C . 2011 . Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study . Oncology , 81 : 395 – 402 .
   PubMed Web of Science ®Google Scholar
• 1993 . The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma . N Engl J Med , 329 : 987 – 994 .
   PubMed Web of Science ®Google Scholar
• 1997 . The Non-Hodgkin's Lymphoma Classification Project: A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma . Blood , 89 : 3909 – 3918 .
   PubMed Web of Science ®Google Scholar
• Coiffier , B , Lepage , E , Briere , J , Herbrecht , R Tilly , H . 2002 . CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma . N Engl J Med , 346 : 235 – 242 .
   PubMed Web of Science ®Google Scholar
• Pfreundschuh , M , Trumper , L , Osterborg , A , Pettengell , R Trneny , M . 2006 . CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group . Lancet Oncol , 7 : 379 – 391 .
   PubMed Web of Science ®Google Scholar
• Feugier , P , Van Hoof , A , Sebban , C , Solal-Celigny , P Bouabdallah , R . 2005 . Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d’Etude des Lymphomes de l’Adulte . J Clin Oncol , 23 : 4117 – 4126 .
   PubMed Web of Science ®Google Scholar
• Ziepert , M , Hasenclever , D , Kuhnt , E , Glass , B Schmitz , N . 2010 . Standard International Prognostic Index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era . J Clin Oncol , 28 : 2373 – 2380 .
   PubMed Web of Science ®Google Scholar
• Jang , G , Yoon , D H , Kim , S , Lee , D H Lee , S W . 2011 . Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma . Korean J Hematol , 46 : 103 – 110 .
   PubMedGoogle Scholar
• Pettengell , R , Johnson , H E , Lugtenburg , P J , Silvestre , A S Duhrsen , U . 2012 . Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma . Support Care Cancer , 20 : 647 – 652 .
   PubMed Web of Science ®Google Scholar
• Dobrila-Dintinjana , R , Trivanovic , D , Zelic , M , Radic , M Dintinjana , M . 2012 . Nutritional support in patients with colorectal cancer during chemotherapy: does it Work? . Hepatogastroenterology , 60 : 475 – 480 .
   Web of Science ®Google Scholar
• Robinson , D L , Loman , D G , Balakas , K and Flowers , M . 2012 . Nutritional screening and early intervention in children, adolescents, and young adults with cancer . J Pediatr Oncol Nurs , 29 : 346 – 355 .
   PubMed Web of Science ®Google Scholar
• Sarhill , N , Mahmoud , F , Walsh , D , Nelson , K A Komurcu , S . 2003 . Evaluation of nutritional status in advanced metastatic cancer . Support Care Cancer , 11 : 652 – 659 .
   PubMed Web of Science ®Google Scholar
• McMillan , D C . 2008 . An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer . Proc Nutr Soc , 67 : 257 – 262 .
   PubMed Web of Science ®Google Scholar
• Tah , P C , Nik Shanita , S and Poh , B K . 2012 . Nutritional status among pediatric cancer patients: a comparison between hematological malignancies and solid tumors . J Spec Pediatr Nurs , 17 : 301 – 311 .
   PubMed Web of Science ®Google Scholar
• D’Angio , R G . 1994 . Is there a role for albumin administration in nutrition support? . Ann Pharmacother , 28 : 478 – 482 .
   PubMed Web of Science ®Google Scholar
• Fleck , A. , Raines , G. , Hawker , F. , Trotter , J. Wallace , P. I. 1985 . Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury . Lancet , 1 : 781 – 784 .
   PubMed Web of Science ®Google Scholar
• Devoto , G , Gallo , F , Marchello , C , Racchi , O Garbarini , R . 2006 . Prealbumin serum concentrations as a useful tool in the assessment of malnutrition in hospitalized patients . Clin Chem , 52 : 2281 – 2285 .
   PubMed Web of Science ®Google Scholar
• Aoki , T , Nishiyama , T , Imahashi , N and Kitamura , K . 2012 . Lymphopenia following the completion of first-line therapy predicts early relapse in patients with diffuse large B cell lymphoma . Ann Hematol , 91 : 375 – 382 .
   PubMed Web of Science ®Google Scholar
• Kim , Y R , Kim , J S , Kim , S J , Jung , H A Kim , W S . 2011 . Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy . J Hematol Oncol , 4 : 34
   PubMed Web of Science ®Google Scholar